ARMP Armata Pharmaceuticals Inc

Price (delayed)

$4.18

Market cap

$104.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.2

Enterprise value

$93.7M

Highlights
The company's quick ratio has surged by 193% QoQ and by 22% YoY
The revenue has soared by 130% since the previous quarter
The company's net income fell by 9% YoY

Key stats

What are the main financial stats of ARMP
Market
Shares outstanding
24.94M
Market cap
$104.25M
Enterprise value
$93.7M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.07
Price to sales (P/S)
45.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.6
Earnings
Revenue
$1.89M
EBIT
-$22.07M
EBITDA
-$20.97M
Free cash flow
-$20.53M
Per share
EPS
-$1.2
Free cash flow per share
-$1
Book value per share
$1.36
Revenue per share
$0.09
TBVPS
$2.41
Balance sheet
Total assets
$52.85M
Total liabilities
$18.83M
Debt
$13.11M
Equity
$34.01M
Working capital
$19.06M
Liquidity
Debt to equity
0.39
Current ratio
4.83
Quick ratio
4.75
Net debt/EBITDA
0.5
Margins
EBITDA margin
-1,110%
Gross margin
100%
Net margin
-1,196.3%
Operating margin
-1,170%
Efficiency
Return on assets
-48.2%
Return on equity
-84.4%
Return on invested capital
-68.4%
Return on capital employed
-46.1%
Return on sales
-1,168.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARMP stock price

How has the Armata Pharmaceuticals stock price performed over time
Intraday
0.72%
1 week
-8.93%
1 month
3.98%
1 year
18.08%
YTD
40.27%
QTD
-12.55%

Financial performance

How have Armata Pharmaceuticals's revenue and profit performed over time
Revenue
$1.89M
Gross profit
$1.89M
Operating income
-$22.1M
Net income
-$22.6M
Gross margin
100%
Net margin
-1,196.3%
The revenue has soared by 130% since the previous quarter
ARMP's gross profit has surged by 130% since the previous quarter
The company's net margin has surged by 56% QoQ
The company's operating margin has surged by 55% QoQ

Growth

What is Armata Pharmaceuticals's growth rate over time

Valuation

What is Armata Pharmaceuticals stock price valuation
P/E
N/A
P/B
3.07
P/S
45.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.6
Armata Pharmaceuticals's EPS has increased by 46% YoY and by 11% QoQ
ARMP's P/B is 92% above its 5-year quarterly average of 1.6 and 10% above its last 4 quarters average of 2.8
The equity has soared by 80% from the previous quarter
The revenue has soared by 130% since the previous quarter
ARMP's price to sales (P/S) is 93% lower than its last 4 quarters average of 653.8

Efficiency

How efficient is Armata Pharmaceuticals business performance
Armata Pharmaceuticals's return on sales has surged by 55% QoQ
ARMP's return on invested capital has surged by 53% year-on-year and by 15% since the previous quarter
Armata Pharmaceuticals's ROA has increased by 23% YoY and by 2.8% from the previous quarter
The company's return on equity rose by 10% YoY

Dividends

What is ARMP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARMP.

Financial health

How did Armata Pharmaceuticals financials performed over time
ARMP's total assets is 181% higher than its total liabilities
ARMP's current ratio has surged by 198% since the previous quarter and by 19% year-on-year
The company's quick ratio has surged by 193% QoQ and by 22% YoY
The company's debt is 61% lower than its equity
The equity has soared by 80% from the previous quarter
ARMP's debt to equity is down by 44% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.